International Journal of Pediatrics Research

Objective To investigate the effect of oral probiotics combined with blue light irradiation in the treatment of neonatal jaundice. Methods A total of 100 children with neonatal jaundice treated in our hospital were selected as research objects. All children were admitted to our hospital from January 2021 to July 2022 for treatment. All children were randomly divided into control group (n=50) and observation group (n=50), and the control group was treated with blue light irradiation. For observation, the children were given oral bifidobacterium triple viable powder adjuvant therapy based on blue light irradiation. After treatment, the serum bilirubin level, clinical efficacy, yellowing time, length of hospital stay and other related indicators were compared between the two groups. Results After treatment intervention, the treatment effective rate of the control group reached 74%, the observation group of children overall treatment effective rate reached 96%, the two groups compared with significant difference, P<0.05. Compared with the control group, the serum total bilirubin and bilirubin in the observation group were significantly lower after treatment, the difference was significant (P<0.05). Conclusion In the clinical treatment of neonatal jaundice, the combination of oral probiotics and blue light irradiation can give full play to the synergistic effect of the two, accelerate the serum bilirubin excretion in children from multiple ways, so as to make the yellowing time of children faster, which has great clinical promotion value.

neonatal jaundice; Blue light exposure; Probiotics